Patients' and doctors' assessment of adalimumab self injection: a multicenter questionnaire survey- Pearl survey 2

Patients' and doctors' assessment of adalimumab self injection: a multicenter questionnaire survey- Pearl survey 2 - Assessment of adalimumab self injection in the patients and doctors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035842

Enrollment

300

Registered

2019-02-12

Start date

2018-12-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: IBD (inflammatory bowel disease) patients who under treatment of adalimumab self injection

Exclusion criteria

Exclusion criteria: Patients who do not give consent to participate in the survey.

Design outcomes

Primary

Measure	Time frame
Satisfaction rate of adalimumab self injection for pen type	—

Secondary

Measure	Time frame
Pain of adalimumab self injection. Adherence of adalimumab self injection. Anxiety of adalimumab self injection. Difference in recognition of adalimumab self-injection among patients - doctors etc	—

Countries

Japan

Contacts

Public ContactNoriko Kamata

Osaka City University Department of Gastroenterology

nkamata@med.osaka-cu.ac.jp0666453811

Outcome results